Financials

  • Market Capitalization 348.84 M
  • Employee 35
  • Founded 2008
  • CEO N/A
  • Website www.inhibikase.com
  • Headquarter Delaware, United States
  • FIGI BBG005TP2339
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.61
市销率
54.94

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3142
AGEN
Agenus Inc. - Common Stock
8.09 USD+1.25%-2.29%+3.06%+90.80%364.22 M USD
3143
DMAC
DiaMedica Therapeutics Inc. - Common Stock
6.75 USD+4.65%+1.05%+2.27%+27.60%364.00 M USD
3189
PALI
Palisade Bio, Inc. - Common Stock
1.99 USD+1.53%-6.13%+3.65%+17.06%346.80 M USD
3206
SABS
SAB Biotherapeutics, Inc. - Common Stock
3.75 USD+1.35%-2.85%-1.32%+63.04%341.20 M USD

新闻